AMBER BEDLEY: Open Payments
NPI 1245705425 · CARROLLTON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$734 in 31 payments from 15 companies in 2025. Trend: 2023 $259 · 2024 $1,014 · 2025 $734
Food & beverage: $734
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $162 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $77 |
| GENZYME CORPORATION | 3 | $72 |
| Enterra Medical, Inc. | 1 | $64 |
| Novo Nordisk Inc | 2 | $58 |
| Phathom Pharmaceuticals, Inc. | 2 | $46 |
| Janssen Biotech, Inc. | 1 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Madrigal Pharmaceuticals | 1 | $36 |
| PFIZER INC. | 2 | $35 |
Products named: DUPIXENT, CREON, XIFAXAN, Wegovy, VOQUEZNA, SKYRIZI, TREMFYA, REZDIFFRA.
Industry payments across GA — which companies pay providers there.
